Top News : Repros Therapeutics (NASDAQ:RPRX), J. C. Penney Company (NYSE:JCP), Sutron (NASDAQ:STRN), Microsoft Corporation (NASDAQ:MSFT), Journal Communications Inc. (NYSE:JRN)
Repros Therapeutics Inc. (NASDAQ:RPRX) is up almost 20% during trading, on news of successful trial results for its low testosterone treating drug. The trial of the drug was being conducted against a leading treatment of low testosterone and a placebo with two primary end-points. Repros’s drug Androxal showed better results in both measures of the trial and also had statistically significant results for the secondary … Continue reading Top News : Repros Therapeutics (NASDAQ:RPRX), J. C. Penney Company (NYSE:JCP), Sutron (NASDAQ:STRN), Microsoft Corporation (NASDAQ:MSFT), Journal Communications Inc. (NYSE:JRN)